Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk Academic Article uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
  • Breast Neoplasms
  • Receptors, Estrogen
  • Receptors, Progesterone

abstract

  • These data add to the growing evidence that supports the regular use of aspirin and other NSAIDs (which may operate through inhibition of estrogen biosynthesis) as effective chemopreventive agents for breast cancer.

publication date

  • May 26, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.291.20.2433

PubMed ID

  • 15161893

Additional Document Info

start page

  • 2433

end page

  • 40

volume

  • 291

number

  • 20